Updated: 5 days ago
Medically reviewed by Dr . Wang
Key Takeaways |
How does ChinaCureLink match my case? Treatment: Hospital matching and care coordination; the receiving medical team recommends treatment. Condition: Serious diseases requiring specialist assessment; suitability depends on the individual case. Availability in China: Depends on the hospital's review and availability of the proposed service. Location: The city and provider follow the case assessment. Estimated cost: A case-specific quotation is needed; no fixed price is provided here. Eligibility: The receiving hospital assesses suitability; clinical trials have additional eligibility requirements. Important: A shortlist does not guarantee acceptance, treatment benefit or fitness to travel. |
Introduction
ChinaCureLink starts with your records and medical needs, then identifies relevant hospitals or specialists for review before you decide whether to travel. This guide explains how ChinaCureLink matches international patients with Chinese hospitals, what happens after you submit records, and which decisions belong to the treating medical team.
Why Isn't the Most Famous Chinese Hospital Automatically the Right One for Me?
The relevant department and treating specialist matter more to your decision than a hospital name alone. A useful recommendation explains how that provider's work relates to your diagnosis and the medical question you need answered.
The Centers for Disease Control and Prevention (CDC) advises medical travellers to consider the destination, facility and treating healthcare professional. American Medical Association guidance reproduced in the CDC Yellow Book also supports access to physician licensing, facility accreditation and outcomes information. Accreditation does not guarantee a successful outcome.
For ChinaCureLink hospital matching, the practical question is: why is this particular provider being considered for my case? Ask which department would review the records, what expertise is relevant, and which questions remain unanswered.
International Organization for Standardization (ISO) standard ISO 22525:2020 sets service requirements and recommendations for medical-tourism facilitators and healthcare providers. Citing it here does not establish that ChinaCureLink is certified to the standard.
Table of Content
What Records Does ChinaCureLink Need Before Matching My Case?
Start with records that explain your diagnosis, current condition and previous treatment. The exact checklist should be confirmed for your disease and the receiving hospital.
Records to prepare, where relevant | What they help clarify |
Recent specialist summary and your main question | The diagnosis, current problem and purpose of the review |
Pathology report, if tissue has been examined | The findings from examination of cells or tissue and the reported diagnosis |
Imaging reports and original scan files, if requested | The documented findings and material the hospital may need to review |
Biomarker or genetic test reports, if already performed | Biological features that may be relevant to treatment or trial eligibility |
Treatment history, including dates and responses | What has been tried, what happened and any important side effects |
Current medicines, allergies and other health conditions | Issues the reviewing team may need to consider |
Recent laboratory results and current symptoms | The patient's present condition and questions about treatment suitability |
This is a preparation checklist, not a verified ChinaCureLink protocol For cancer cases, the National Cancer Institute (NCI) explains that pathology and relevant molecular findings inform diagnosis and treatment planning. A pathology second opinion may require the original slides or tissue block.
If something is missing, ask what is essential for the initial enquiry and what is needed for a medical opinion. Do not arrange additional tests solely to complete this checklist without your doctor's advice.
Before sharing records, ask who will receive them, whether translation is needed, and how you will consent to disclosure. The World Medical Association (WMA) recommends explaining who can access medical information, including non-medical staff such as interpreters.
What Factors Are Used to Identify Appropriate Hospitals and Specialists?
The shortlist should connect the patient's medical needs with the relevant clinical service and practical access. These are the proposed assessment questions for ChinaCureLink hospital matching; the internal criteria require confirmation.
Matching factor | What the recommendation should explain |
Diagnosis and current disease status | Why this department or specialist is relevant to the recorded condition |
Previous treatment and the current question | Whether the enquiry concerns diagnosis, a second opinion, further treatment or research options |
Specialist experience | What supports the provider's experience with the condition or proposed procedure |
Treatment pathway | Whether the proposal concerns approved treatment for the stated indication or a clinical trial |
Hospital capability | Which assessment, treatment and complication-management services the case may require |
Current access | Whether the hospital can review the enquiry and what further screening is needed |
Practical arrangements | Language support, accessibility, caregiver needs and communication after returning home |
For cancer care, NCI guidance supports asking about the clinician's relevant experience and the facility's experience treating the condition. The table applies those principles as questions for assessing a shortlist; it does not verify any particular hospital or ChinaCureLink's implementation.
How Is Eligibility Checked Before Treatment Is Discussed?
Eligibility requires medical assessment by the receiving team. For a clinical trial, the study's rules may consider health, treatment history and tumour characteristics. A treatment's approval status and a trial's recruitment status must be checked for the exact proposal; a trial listing does not establish that you qualify.
ChinaCureLink's role is to organise the relevant information and coordinate that assessment. It does not replace the treating physician's decision about diagnosis or treatment.
Considering This Treatment in China?
Request a Preliminary Case Review to have your records assessed and identify up to three Chinese hospitals or specialists appropriate for your medical needs.
We review the records documenting your diagnosis, pathology, biomarkers and previous treatments to identify potential treatment paths for hospital assessment and help match your case before any travel decision is made. The receiving physicians assess medical suitability.
Why Might I Receive Up to Three Hospital or Specialist Options?
The purpose is to let you compare relevant routes to care. The proposed number of options depends on the case and which providers may be appropriate.
Service detail | Proposed scope | Source or verification status |
Hospital or specialist shortlist | Up to three relevant options; fewer may be appropriate | VERIFY V1: supplied service description; confirm the internal matching policy before publication |
ChinaCureLink hospital matching should make the reasoning behind each option visible. Ask for the department or specialist, why they fit the case, what the hospital has actually confirmed, and what remains conditional.
A name on a shortlist is not an admission offer. If an option depends on additional tests or a trial place, that condition should be clear. If no suitable route is identified, ask for that conclusion to be stated plainly; adding names would not resolve the medical question.
When comparing providers, use comparable evidence. An outcome reported for a different diagnosis, treatment or patient group may not answer your question about your own case.
What Happens After My Case Is Sent to a Chinese Hospital?
The hospital evaluates the information and decides whether it can offer further assessment or a treatment proposal. Medical decisions belong to physicians working with the patient, as the WMA's medical-tourism guidance states.
ChinaCureLink's proposed coordination sequence is: records → clinical needs → relevant providers → shortlist → hospital review → proposal, if appropriate.
The hospital's response may request missing information, recommend further assessment, suggest a consultation or explain why the case cannot proceed.
Before making travel arrangements, ask for a written response covering
The clinician or department responsible for the medical assessment
The proposed next step and any additional tests required.
The treatment's purpose, evidence, important risks and alternatives.
Whether the route is approved treatment or a clinical trial, with its eligibility conditions.
The expected arrangements for monitoring and follow-up.
For an international patient, request an itemised quotation separating hospital charges, facilitator fees, interpretation and travel-related services. Ask which costs are excluded and how complications or changes to the plan are handled. Confirm overseas treatment and follow-up coverage directly with your insurer; do not assume reimbursement.
What Risks or Uncertainties Should I Understand, and When Should I Contact My Doctor?
Hospital matching cannot remove uncertainty about acceptance, suitability, treatment results, timing or final cost. A recommendation should show what is known and what still depends on medical review.
Risks and Side Effects
Treatment does not work for everyone, and side effects depend on the actual treatment proposed. Ask the receiving specialist to explain likely benefits, important harms and alternatives for your condition. Clinical trials assess specific research questions and should not be presented as guaranteed access to a beneficial therapy.
International care also requires planning for complications and follow-up. Discuss travel fitness and care after returning home with your doctors before you book. Do not delay needed local care while waiting for an overseas response.
When to Contact Your Doctor
Contact your treating team if your condition worsens or you are concerned about a complication while waiting. Seek urgent local medical care for severe breathing difficulty, chest pain, uncontrolled bleeding or new confusion; use your local emergency number when necessary. Do not wait for a facilitator to respond.
How ChinaCureLink Can Help
ChinaCureLink, a Medebound HEALTH company, acts as a medical facilitator and patient advocate. Its stated independent model considers relevant providers beyond a single hospital.
“We don't begin with the hospital. We begin with the medical case.”
How can ChinaCureLink help you choose? The proposed support connects the records, provider options and hospital response so you can understand the next decision.
Case review: Organise the diagnosis, pathology, biomarkers and previous treatments for assessment and identify questions for the receiving specialists.
Hospital coordination: Help match the case with up to three relevant hospitals or specialists and coordinate their review.
Online consultation before travel: Help arrange a specialist discussion where the receiving hospital offers it. Availability, format, interpretation and fees must be confirmed.
Coordination support: Help with records, appointments and communication around the agreed care arrangements. Confirm the included services before proceeding.
Ask for a clear explanation of service fees and any provider relationships relevant to your referral. The treating hospital remains responsible for clinical assessment and care.
Get a Second Opinion Before Fly to China
For suitable cases, ChinaCureLink can then coordinate an online consultation with the specialist to discuss the technical treatment details directly. The purpose is to help the patient understand which treatment option and which specialist center may be most appropriate before making an international treatment decision.
What Patients Say About ChinaCureLink & Medebound HEALTH
China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.
Frequently Asked Questions
How Does ChinaCureLink Choose Hospitals for Me?
ChinaCureLink hospital matching starts with your diagnosis, previous treatments and current medical needs, then identifies relevant hospitals or specialists for review. The proposed process also considers the required service and practical access.
Will I Get More Than One Hospital Option?
You may receive up to three relevant hospital or specialist options, depending on your case. Fewer options may be appropriate, and a shortlist does not guarantee acceptance.
Can ChinaCureLink Guarantee a Hospital Will Accept Me?
No. The receiving hospital decides whether it can accept your case and whether a proposed treatment or trial is suitable. Sending records or receiving a shortlist is not an acceptance decision.
Do I Need All My Medical Records Before You Can Match Me?
You can begin an enquiry with the records you have, but matching and a meaningful medical opinion may require additional reports or files. ChinaCureLink can explain what the receiving hospital needs.
Can I Speak to the Chinese Specialist Before Travelling?
An online consultation may be possible if the receiving hospital offers it for your case. Availability, format, interpretation and any fee must be confirmed before booking.
About ChinaCureLink
ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.
ChinaCureLink is proudly affiliated with Medebound HEALTH — founded by US physicians, with over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized by Forbes and it is one of the most trusted patient cross-border concierge service company across North America and the Asia Pacific.
Disclaimer
This article is for informational purposes only and is not medical or financial advice. Treatment eligibility, protocols, and costs vary by individual case — confirm specifics with a coordinator and treating physician before making any decisions.
Numbered, dated sources
1. Centers for Disease Control and Prevention. Medical Tourism, CDC Yellow Book 2026. Published 23 April 2025. Accessed 8 October 2026. Includes the American Medical Association's guiding principles on licensing, accreditation and outcomes information.
2. International Organization for Standardization. ISO 22525:2020 — Tourism and related services — Medical tourism — Service requirements. Published December 2020. Accessed 8 October 2026. Public abstract used; no certification claim is made.
3. World Medical Association. WMA Statement on Medical Tourism. Adopted October 2018; webpage dated 6 October 2018. Accessed 8 October 2026.
4. National Cancer Institute. Surgical Pathology Reports. No update date displayed in the retrieved page. Accessed 8 October 2026.
5. National Cancer Institute. How Do Clinical Trials Work?. Updated 8 November 2024. Accessed 8 October 2026. Used for general research and eligibility principles, not confirmation of any Chinese trial.
6. National Cancer Institute. Finding Cancer Care. Updated 28 August 2024. Accessed 8 October 2026. Used for general provider-selection and second-opinion principles.
7. MedlinePlus, U.S. National Library of Medicine. Recognizing medical emergencies.
Review date shown: 8 January 2025. Accessed 8 October 2026.
